Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01255943 · ClinicalTrials.gov registry record
Testing Spread and Implementation of Novel Methicillin Resistant Staphylococcal Aureus (MRSA)-Reducing Practices
A clinical trial, sponsored by MaineHealth.
- Completed
- Registry status
- 175
- Enrollment target
NCT01255943 is a clinical trial that has completed, run by MaineHealth. The registered enrollment target is 175 participants.
The verdict
NCT01255943 has completed, sponsored by MaineHealth.
- COMPLETED
- Registry status
- 175 participants
- Enrollment target
Study Summary
The purpose of this study is to implement strategies for improved efficiency and waste reduction ("Toyota Lean") and positive deviance, a social behavioral change process, utilizing frontline healthcare personnel to reduce infection bloodstream infection and MRSA infection in outpatient dialysis care. In two outpatient dialysis units, dialysis unit healthcare staff will be educated in Toyota lean techniques and conduct periodic "discovery and action" dialogues to identify and implement care process changes to reduce infection. Outcomes to be monitored will include incidence of bloodstream infections and MRSA infections of all types. Data will be assessed at quarterly intervals using interrupted time series analysis.
Interventions
- BEHAVIORAL healthcare staff processes for infection prevention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2010-07 |
| Est. Completion | 2012-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01255943
The ClinicalTrials.gov registry entry for NCT01255943 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MaineHealth, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which healthcare staff processes for infection prevention is the first listed.
NCT01255943 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01255943 about?
NCT01255943 is a clinical study titled "Testing Spread and Implementation of Novel Methicillin Resistant Staphylococcal Aureus (MRSA)-Reducing Practices". The purpose of this study is to implement strategies for improved efficiency and waste reduction ("Toyota Lean") and positive deviance, a social behavioral change process, utilizing frontline healthcare personnel to reduce infection bloodstream infection and MRSA infection in outpatient dialysis car...
What is the current status of trial NCT01255943?
This trial is currently completed. The enrollment target is 175 participants. The study started on 2010-07. Estimated completion is 2012-04.
What interventions are being tested in trial NCT01255943?
The interventions under investigation include: healthcare staff processes for infection prevention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01255943?
This trial is sponsored by MaineHealth, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.